BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7296969)

  • 1. Changes in bone mineral content evaluated by photon absorptiometry before the start of active uremia treatment.
    Lindergård B
    Clin Nephrol; 1981 Sep; 16(3):126-30. PubMed ID: 7296969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral content in renal transplant patients.
    Nielsen HE
    Clin Nephrol; 1978 Nov; 10(5):196-200. PubMed ID: 365405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of diminished bone mineral content following renal transplantation in childhood.
    Chesney RW; Rose PG; Mazess RB
    Pediatrics; 1984 Apr; 73(4):459-66. PubMed ID: 6369239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations of bone mineral content, ash weight and bone mass: implication for correction of bone mineral content for bone size.
    Nielsen HE; Mosekilde L; Mosekilde L; Melsen B; Christensen P; Olsen KJ; Melsen F
    Clin Orthop Relat Res; 1980; (153):241-7. PubMed ID: 7449223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of bone mineral content in patients on regular hemodialysis.
    Eeckhout E; Verbeelen D; Sennesael J; Kaufman L; Jonckheer MH
    Nephron; 1989; 52(2):158-61. PubMed ID: 2739850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.
    Haworth CS; Jones AM; Adams JE; Selby PL; Webb AK
    J Cyst Fibros; 2004 Dec; 3(4):233-6. PubMed ID: 15698940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
    Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE
    Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal plasma levels of calcitonin and bone mineral mass in normal and uremic women. Effect of menopause.
    Corghi E; Ortolani S; Bianchi ML; Favini P; Vigo P; Polli EE
    Biomed Pharmacother; 1984; 38(5):263-5. PubMed ID: 6525424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo bone mineral analysis throughout skeletal growth in rats: differences due to sex or vitamin D deficiency.
    Awbrey BJ; Hagaman JR; Lester GE; Talmage RV
    J Orthop Res; 1985; 3(4):456-63. PubMed ID: 4067704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone volume and mineral density of iliac crest spongiosa in uremia.
    Sieberth HG; Ritz E; Januschke J; Krempien B; Wesch H; Pohl I; Häckel E
    Clin Nephrol; 1975 Dec; 4(6):237-42. PubMed ID: 1204262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral content in patients on prolonged maintenance hemodialysis: a three year follow-up study.
    Rickers H; Christensen M; Rødbro P
    Clin Nephrol; 1983 Dec; 20(6):302-7. PubMed ID: 6641032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral content in systemic sclerosis measured by photonabsorptiometry.
    Serup J; Hagdrup H; Tvedegaard E
    Acta Derm Venereol; 1983; 63(3):235-7. PubMed ID: 6192639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients.
    Mautalen C; González D; Mazure R; Vázquez H; Lorenzetti MP; Maurino E; Niveloni S; Pedreira S; Smecuol E; Boerr LA; Bai JC
    Am J Gastroenterol; 1997 Feb; 92(2):313-8. PubMed ID: 9040213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone fluoride in patients with uremia maintained by chronic hemodialysis.
    Kim D; Del Greco F; Hefferen JJ; Levin NW
    Trans Am Soc Artif Intern Organs; 1970; 16():474-8. PubMed ID: 5454201
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hyperthyroidism and its treatment on bone mineral content.
    Toh SH; Claunch BC; Brown PH
    Arch Intern Med; 1985 May; 145(5):883-6. PubMed ID: 3838875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of 24 patients on regular hemodialysis treatment (RDT) for 16-23 years in a single unit.
    Bazzi C; Arrigo G; Luciani L; Casazza F; Saviotti M; Malaspina D; Bonucci E; Ballanti P; Amaducci S; Lattuada P
    Clin Nephrol; 1995 Aug; 44(2):96-107. PubMed ID: 8529316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone disorder in long-term survival after gastrectomy with reference to bone mineral content].
    Nishimura O; Sakamoto H; Furumoto T; Nosaka K; Kouno K; Hisaki T; Koga S
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1684-94. PubMed ID: 3447034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiologic study of the mineral content of the phalanges of normal persons and patients in chronic hemodialysis].
    Kaye M; Lajzerowicz R; Jones V
    Union Med Can; 1971 Mar; 100(3):480-4. PubMed ID: 5555755
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mineralometry and vitamin D in hemodialyzed patients].
    Bustamante J; Moser F; Leski M
    Rev Clin Esp; 1978 Aug; 150(3-4):129-32. PubMed ID: 715270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.